The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Serim Research sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Serim Research is a medical equipment company that develops, manufactures, and markets test strips. The company’s flagship product, Serim test strips offer a convenient alternative to intricate and burdensome multi-step wet chemistry colorimetric assays. These strips allow for on-site sample analysis (point-of-use) through a straightforward process that requires minimal or no special equipment, eliminating the hassle of storing, handling, and mixing liquid reagents. It also provides customized services, contract manufacturing services, product development and product evaluation services. Serim Research is headquartered in Elkhart, Indiana, the US.
The key metrics of Serim Research related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Serim Research is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Serim Research.
For a detailed understanding of the performance of Serim Research, buy the report here.